Cargando…

Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial

BACKGROUND: The preliminary results of our phase II randomized trial reported comparable functional sphincter preservation rates and short-term survival outcomes between patients undergoing total mesorectal excision (TME) with or without preoperative concurrent chemoradiotherapy (CCRT). We now repor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fulong, Fan, Wenhua, Peng, Jianhong, Lu, Zhenhai, Pan, Zhizhong, Li, Liren, Gao, Yuanhong, Li, Hui, Chen, Gong, Wu, Xiaojun, Ding, Peirong, Zeng, Zhifan, Wan, Desen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302296/ https://www.ncbi.nlm.nih.gov/pubmed/30572939 http://dx.doi.org/10.1186/s40880-018-0342-8

Ejemplares similares

Addition of oxaliplatin to capecitabine-based preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcome of a phase II study
por: Peng, Jianhong, et al.
Publicado: (2017)

Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer
por: Lin, Junzhong, et al.
Publicado: (2016)

Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer
por: Peng, Jianhong, et al.
Publicado: (2016)

Oncologic comparison between nonradical management and total mesorectal excision in good responders after chemoradiotherapy in patients with mid-to-low rectal cancer
por: Lee, Ja Kyung, et al.
Publicado: (2021)

Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision
por: Zuo, Zhi-Gui, et al.
Publicado: (2016)

A systematic review and meta-analysis of minimally invasive total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer
por: Gang, Du Yong, et al.
Publicado: (2023)

High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy
por: Zhou, Wenhao, et al.
Publicado: (2019)

Total mesorectal excision for the treatment of rectal cancer
por: Zedan, Ali, et al.
Publicado: (2015)

Local Excision ± Chemoradiotherapy vs. Total Mesorectal Excision for Early Rectal Cancer: Case-Matched Analysis of Long-Term Results
por: Pacevicius, Julius, et al.
Publicado: (2021)

Efficacy and safety of a NiTi CAR 27 compression ring for end-to-end anastomosis compared with conventional staplers: A real-world analysis in Chinese colorectal cancer patients
por: Lu, Zhenhai, et al.
Publicado: (2016)

Urinary dysfunction in women following total mesorectal excision versus partial mesorectal excision for treatment of rectal cancer
por: Chill, Henry H., et al.
Publicado: (2021)

Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis
por: Lee, Jii Bum, et al.
Publicado: (2021)

Robotic total mesorectal excision for the treatment of rectal cancer
por: Baik, Seung Hyuk, et al.
Publicado: (2007)

Update on Robotic Total Mesorectal Excision for Rectal Cancer
por: Giuratrabocchetta, Simona, et al.
Publicado: (2021)

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy
por: Solanki, Abhishek A, et al.
Publicado: (2013)

Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis
por: Peng, Jianhong, et al.
Publicado: (2017)

Long-term Outcomes of Lower Rectal Cancer Patients Treated with Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection after Preoperative Radiotherapy or Chemoradiotherapy
por: Sakamoto, Wataru, et al.
Publicado: (2021)

Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients
por: Sterzing, Florian, et al.
Publicado: (2015)

Learning Curve of Robotic-Assisted Total Mesorectal Excision for Rectal Cancer
por: Tang, Bo, et al.
Publicado: (2022)

Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
por: He, Fang, et al.
Publicado: (2022)

Voiding Dysfunction after Total Mesorectal Excision in Rectal Cancer
por: Kim, Jae Heon, et al.
Publicado: (2011)

The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study
por: Akgun, Erhan, et al.
Publicado: (2017)

Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation
por: Han, Yoon Dae, et al.
Publicado: (2015)

Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer
por: Peng, Jianhong, et al.
Publicado: (2017)

Long-Term Outcome of Oxaliplatin and Capecitabine (XELOX) Concomitant with Neoadjuvant Radiotherapy and Extended to the Resting Period in High Risk Locally Advanced Rectal Cancer
por: Tang, Jinghua, et al.
Publicado: (2018)

Female urogenital dysfunction following total mesorectal excision for rectal cancer
por: Daniels, Ian R, et al.
Publicado: (2006)

Transumbilical laparoendoscopic single-site total mesorectal excision for rectal carcinoma
por: Michalik, Maciej, et al.
Publicado: (2012)

Transanal Total Mesorectal Excision With Single-Incision Laparoscopy for Rectal Cancer
por: Foo, Dominic Chi-chung, et al.
Publicado: (2016)

Transanal Total Mesorectal Excision for Rectal Cancer: Perioperative and Oncological Outcomes
por: Hur, Hyuk
Publicado: (2018)

From Total Mesorectal Excision to Organ Preservation for the Treatment of Rectal Cancer
por: Baek, Seong Kyu
Publicado: (2019)

Comparing outcomes of robotic versus open mesorectal excision for rectal cancer
por: Jimenez-Rodriguez, Rosa M, et al.
Publicado: (2022)

Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer
por: Maykel, Justin A., et al.
Publicado: (2022)

Association of Transanal Total Mesorectal Excision With Local Recurrence of Rectal Cancer
por: Caycedo-Marulanda, Antonio, et al.
Publicado: (2021)

Oncological monitoring after transanal total mesorectal excision for rectal neoplasia
por: Gachabayov, M., et al.
Publicado: (2023)

Oncological outcomes after transanal total mesorectal excision for rectal cancer
por: Francis, Nader K, et al.
Publicado: (2023)

Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer: a meta-analysis of short-term outcomes
por: Lin, Dezheng, et al.
Publicado: (2019)

Short- and mid-term outcomes of transanal versus laparoscopic total mesorectal excision for low rectal cancer: a meta-analysis
por: Ren, Jingqing, et al.
Publicado: (2021)

Transanal Total Mesorectal Excision (TaTME) versus Laparoscopic Total Mesorectal Excision for Lower Rectal Cancer: A Propensity Score-Matched Analysis
por: Lin, Yueh-Chen, et al.
Publicado: (2022)

Laparoscopic intersphincteric resection vs. transanal total mesorectal excision in overweight patients with low rectal cancer
por: Li, Zhengbiao, et al.
Publicado: (2022)

Outcomes of robotic low anterior resection versus transanal total mesorectal excision for rectal cancer
por: Buan, J L B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kslhnbmjqlj8v50s09587d26cv